APOE
|
ALZHEIMER DISEASE (70)
|
VDR
|
PROSTATIC NEOPLASMS (10)
|
|
CORONARY DISEASE (8)
| |
OSTEOPOROSIS, POSTMENOPAUSAL (8)
|
|
CARDIOVASCULAR DISEASES (7)
| |
BREAST NEOPLASMS (7)
|
|
MYOCARDIAL INFARCTION (6)
| |
DIABETES MELLITUS, TYPE 1 (6)
|
|
DIABETES MELLITUS, TYPE 2 (6)
| |
OSTEOPOROSIS (6)
|
ACE
|
HYPERTENSION (47)
|
MTHFR
|
NEURAL TUBE DEFECTS (6)
|
|
DIABETES MELLITUS, TYPE 2 (25)
| |
COLORECTAL NEOPLASMS (5)
|
|
MYOCARDIAL INFARCTION (17)
| |
DIABETES MELLITUS, TYPE 2 (5)
|
|
CORONARY DISEASE (16)
| |
ESOPHAGEAL NEOPLASMS (5)
|
|
DIABETIC NEPHROPATHIES (15)
| |
ADENOCARCINOMA (4)
|
HLA-DQB1
|
DIABETES MELLITUS, TYPE 1 (30)
|
CYP17A1
|
BREAST NEOPLASMS (10)
|
|
PAPILLOMAVIRUS INFECTIONS (7)
| |
PROSTATIC NEOPLASMS (9)
|
|
CELIAC DISEASE (6)
| |
PROSTATIC HYPERPLASIA (4)
|
|
AUTOIMMUNE DISEASES (5)
| |
OSTEOPOROSIS, POSTMENOPAUSAL (3)
|
|
TUBERCULOSIS, PULMONARY (5)
| |
ENDOMETRIAL NEOPLASMS (2)
|
DRD2
|
ALCOHOLISM (17)
|
ADRB2
|
ASTHMA (12)
|
|
SCHIZOPHRENIA (14)
| |
OBESITY (10)
|
|
PERSONALITY DISORDER (2)
| |
HYPERTENSION (8)
|
|
DEPRESSIVE DISORDER (2)
| |
DIABETES MELLITUS, TYPE 2 (4)
|
|
DYSKINESIA, DRUG INDUCED (2)
| |
BRONCHIAL HYPERREACTIVITY (4)
|
PPARG
|
DIABETES MELLITUS, TYPE 2 (18)
|
NOS3
|
HYPERTENSION (20)
|
|
OBESITY (11)
| |
MYOCARDIAL INFARCTION (18)
|
|
DIABETES MELLITUS (6)
| |
CORONARY ARTERY DISEASE (15)
|
|
INSULIN RESISTANCE (4)
| |
CORONARY DISEASE (12)
|
|
GLUCOSE INTOLERANCE (2)
| |
DIABETES MELLITUS, TYPE 2 (10)
|